Anti-Aging Drugs and the Related Signal Pathways

Aging is a multifactorial biological process involving chronic diseases that manifest from the molecular level to the systemic level. From its inception to 31 May 2022, this study searched the PubMed, Web of Science, EBSCO, and Cochrane library databases to identify relevant research from 15,983 art...

Full description

Bibliographic Details
Main Authors: Nannan Du, Ruigang Yang, Shengrong Jiang, Zubiao Niu, Wenzhao Zhou, Chenyu Liu, Lihua Gao, Qiang Sun
Format: Article
Language:English
Published: MDPI AG 2024-01-01
Series:Biomedicines
Subjects:
Online Access:https://www.mdpi.com/2227-9059/12/1/127
_version_ 1797340105118056448
author Nannan Du
Ruigang Yang
Shengrong Jiang
Zubiao Niu
Wenzhao Zhou
Chenyu Liu
Lihua Gao
Qiang Sun
author_facet Nannan Du
Ruigang Yang
Shengrong Jiang
Zubiao Niu
Wenzhao Zhou
Chenyu Liu
Lihua Gao
Qiang Sun
author_sort Nannan Du
collection DOAJ
description Aging is a multifactorial biological process involving chronic diseases that manifest from the molecular level to the systemic level. From its inception to 31 May 2022, this study searched the PubMed, Web of Science, EBSCO, and Cochrane library databases to identify relevant research from 15,983 articles. Multiple approaches have been employed to combat aging, such as dietary restriction (DR), exercise, exchanging circulating factors, gene therapy, and anti-aging drugs. Among them, anti-aging drugs are advantageous in their ease of adherence and wide prevalence. Despite a shared functional output of aging alleviation, the current anti-aging drugs target different signal pathways that frequently cross-talk with each other. At present, six important signal pathways were identified as being critical in the aging process, including pathways for the mechanistic target of rapamycin (mTOR), AMP-activated protein kinase (AMPK), nutrient signal pathway, silent information regulator factor 2-related enzyme 1 (SIRT1), regulation of telomere length and glycogen synthase kinase-3 (GSK-3), and energy metabolism. These signal pathways could be targeted by many anti-aging drugs, with the corresponding representatives of rapamycin, metformin, acarbose, nicotinamide adenine dinucleotide (NAD<sup>+</sup>), lithium, and nonsteroidal anti-inflammatory drugs (NSAIDs), respectively. This review summarized these important aging-related signal pathways and their representative targeting drugs in attempts to obtain insights into and promote the development of mechanism-based anti-aging strategies.
first_indexed 2024-03-08T09:57:13Z
format Article
id doaj.art-c7fb9df090724bcba7496736d47e7f47
institution Directory Open Access Journal
issn 2227-9059
language English
last_indexed 2024-03-08T09:57:13Z
publishDate 2024-01-01
publisher MDPI AG
record_format Article
series Biomedicines
spelling doaj.art-c7fb9df090724bcba7496736d47e7f472024-01-29T13:47:22ZengMDPI AGBiomedicines2227-90592024-01-0112112710.3390/biomedicines12010127Anti-Aging Drugs and the Related Signal PathwaysNannan Du0Ruigang Yang1Shengrong Jiang2Zubiao Niu3Wenzhao Zhou4Chenyu Liu5Lihua Gao6Qiang Sun7Frontier Biotechnology Laboratory, Beijing Institute of Biotechnology, Beijing 100071, ChinaFrontier Biotechnology Laboratory, Beijing Institute of Biotechnology, Beijing 100071, ChinaThe Meta-Center, 29 Xierqi Middle Rd, Beijing 100193, ChinaFrontier Biotechnology Laboratory, Beijing Institute of Biotechnology, Beijing 100071, ChinaFrontier Biotechnology Laboratory, Beijing Institute of Biotechnology, Beijing 100071, ChinaFrontier Biotechnology Laboratory, Beijing Institute of Biotechnology, Beijing 100071, ChinaFrontier Biotechnology Laboratory, Beijing Institute of Biotechnology, Beijing 100071, ChinaFrontier Biotechnology Laboratory, Beijing Institute of Biotechnology, Beijing 100071, ChinaAging is a multifactorial biological process involving chronic diseases that manifest from the molecular level to the systemic level. From its inception to 31 May 2022, this study searched the PubMed, Web of Science, EBSCO, and Cochrane library databases to identify relevant research from 15,983 articles. Multiple approaches have been employed to combat aging, such as dietary restriction (DR), exercise, exchanging circulating factors, gene therapy, and anti-aging drugs. Among them, anti-aging drugs are advantageous in their ease of adherence and wide prevalence. Despite a shared functional output of aging alleviation, the current anti-aging drugs target different signal pathways that frequently cross-talk with each other. At present, six important signal pathways were identified as being critical in the aging process, including pathways for the mechanistic target of rapamycin (mTOR), AMP-activated protein kinase (AMPK), nutrient signal pathway, silent information regulator factor 2-related enzyme 1 (SIRT1), regulation of telomere length and glycogen synthase kinase-3 (GSK-3), and energy metabolism. These signal pathways could be targeted by many anti-aging drugs, with the corresponding representatives of rapamycin, metformin, acarbose, nicotinamide adenine dinucleotide (NAD<sup>+</sup>), lithium, and nonsteroidal anti-inflammatory drugs (NSAIDs), respectively. This review summarized these important aging-related signal pathways and their representative targeting drugs in attempts to obtain insights into and promote the development of mechanism-based anti-aging strategies.https://www.mdpi.com/2227-9059/12/1/127aginganti-aging drugsrapamycinmetforminacarboseNAD<sup>+</sup>
spellingShingle Nannan Du
Ruigang Yang
Shengrong Jiang
Zubiao Niu
Wenzhao Zhou
Chenyu Liu
Lihua Gao
Qiang Sun
Anti-Aging Drugs and the Related Signal Pathways
Biomedicines
aging
anti-aging drugs
rapamycin
metformin
acarbose
NAD<sup>+</sup>
title Anti-Aging Drugs and the Related Signal Pathways
title_full Anti-Aging Drugs and the Related Signal Pathways
title_fullStr Anti-Aging Drugs and the Related Signal Pathways
title_full_unstemmed Anti-Aging Drugs and the Related Signal Pathways
title_short Anti-Aging Drugs and the Related Signal Pathways
title_sort anti aging drugs and the related signal pathways
topic aging
anti-aging drugs
rapamycin
metformin
acarbose
NAD<sup>+</sup>
url https://www.mdpi.com/2227-9059/12/1/127
work_keys_str_mv AT nannandu antiagingdrugsandtherelatedsignalpathways
AT ruigangyang antiagingdrugsandtherelatedsignalpathways
AT shengrongjiang antiagingdrugsandtherelatedsignalpathways
AT zubiaoniu antiagingdrugsandtherelatedsignalpathways
AT wenzhaozhou antiagingdrugsandtherelatedsignalpathways
AT chenyuliu antiagingdrugsandtherelatedsignalpathways
AT lihuagao antiagingdrugsandtherelatedsignalpathways
AT qiangsun antiagingdrugsandtherelatedsignalpathways